Fact CheckerSign in

NCT06149195Enrolling by invitation

18F-MFBG Cardiac Imaging for Heart Failure Administration

18F-meta-fluorobenzylguanidine Cardiac Imaging for Evaluation of Chronic Heart Failure

Source: ClinicalTrials.gov · Last updated 24 Jan 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The clinical feasibility of 18F-FMBG cardiac PET imaging will be observed in sympathetic nervous system activity in patients with heart failure, predicted cardiac events, guided ICD implantation, and evaluated therapy efficiency.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
100 (estimated)
First submitted
20 Nov 2023
Start date
1 Jan 2024
Primary completion date
31 Dec 2025
Lead sponsor
Sichuan Provincial People's Hospital
NCT number
NCT06149195

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 1 Jan 2024 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • 7\. The patient has contraindications for ICD implantation surgery.

Other illness

  • 1\. Heart failure, heart function NYHA levels ⅠOR Ⅳ.
  • 3\. Heart transplant patients.
  • 4\. Patients with malignant tumors.
  • 5\. Heart valve disease.
  • 6\. Myocardial infarction occurred within the past three months.

Other

  • 2\. The patient has already implanted ICD or CRT.
  • 8\. The patient does not cooperate or is unwilling to conduct the study.

Who the study is looking for

  • 1\. Clinically confirmed patient with chronic heart failure, LVEF ≤ 40%, cardiac function NYHA 2-3 grade, survival period greater than 1 year, evaluated by the Heart Failure Center of Sichuan Provincial People's Hospital.
  • 2\. Chronic heart failure patients were evaluated by the Cardiology Department of Sichuan Provincial People's Hospital 5-10 days before ICD implantation.
  • 3\. All patients above have signed an informed consent form.

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Zhi Ling Ding
Coordinator of this site? Confirm its status
ChengduChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.